UroGen Pharma Ltd News

UroGen Pharma Is Maintained at Buy by D. Boral Capital

Dow JonesDec 6 07:26 ET

UroGen Pharma Price Target Maintained With a $25.00/Share by D. Boral Capital

Dow JonesDec 6 07:26 ET

UroGen Pharma Analyst Ratings

BenzingaDec 6 07:17 ET

TD Cowen Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Announces Target Price $35

Moomoo NewsNov 6 15:31 ET

UroGen Pharma Analyst Ratings

BenzingaNov 6 11:20 ET

EF Hutton Maintains Buy on UroGen Pharma, Maintains $25 Price Target

BenzingaNov 6 11:20 ET

UroGen Pharma Price Target Maintained With a $25.00/Share by EF Hutton

Dow JonesOct 29 07:32 ET

UroGen Pharma Analyst Ratings

BenzingaOct 21 07:28 ET

TD Cowen Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating

Moomoo NewsOct 16 08:31 ET

Oppenheimer Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $40

Moomoo NewsOct 16 08:31 ET

H.C. Wainwright Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $60

Moomoo NewsOct 16 06:31 ET

H.C. Wainwright Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $60

Moomoo NewsOct 14 08:35 ET

EF Hutton Initiates UroGen Pharma Ltd(URGN.US) With Buy Rating, Announces Target Price $25

Moomoo NewsOct 14 07:31 ET

UroGen Pharma Analyst Ratings

BenzingaOct 3 07:39 ET

H.C. Wainwright Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $60

Moomoo NewsOct 3 06:31 ET

Oppenheimer Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $40

Moomoo NewsSep 18 08:33 ET

Guggenheim Initiates UroGen Pharma Ltd(URGN.US) With Buy Rating, Announces Target Price $40

Moomoo NewsAug 22 06:31 ET

UroGen Pharma Analyst Ratings

BenzingaAug 15 12:49 ET

H.C. Wainwright Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $60

Moomoo NewsAug 15 09:31 ET

Oppenheimer Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $40

Moomoo NewsAug 15 08:34 ET